Researcher Profile

Bahriye Aktas

Publications

1,147

Citations

Co-Authors

Active Years

Publications

Open Access Journal Article Molecular Cancer Mar 26, 2025

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

Darren Korbie · Clare Stirzaker · Oleg Gluz · Christine zu Eulenburg +18 more

10.1186/s12943-025-02275-0 6 citations

Journal Article Journal of Clinical Oncology Jan 20, 2025

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia · Komal Jhaveri · Seock-Ah Im · Sonia Pernas +174 more

10.1200/jco.24.00920 113 citations

Open Access Journal Article Geburtshilfe und Frauenheilkunde May 01, 2025

Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer

Diana Lüftner · Hans-Christian Kolberg · Andreas D. Hartkopf · Tanja N. Fehm +27 more

10.1055/a-2515-2366 4 citations

Journal Article Journal of Clinical Oncology Jan 20, 2024

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin · Kathleen Moore · Hye Sook Chon · Jung-Yun Lee +231 more

10.1200/jco.23.02132 287 citations

Journal Article The Lancet Oncology Apr 01, 2020

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M Swain · David Miles · Sung-Bae Kim · Young-Hyuck Im +216 more

10.1016/s1470-2045(19)30863-0 737 citations

Publication Timeline

2025

2024

2020

Frequent Co-Authors

3×

2×

2×

2×

2×

2×

2×

2×

2×

Pedro Emanuel Rubini Liedke

2×